Inventor · disambiguated record
Christopher F. Thompson
Also filed as: THOMPSON CHRISTOPHER · THOMPSON CHRISTOPHER F · THOMPSON CHRISTOPHER FRANCIS
22 granted patents·2 pending applications·144 citations·filing 2003–2015
94Inventor score
Top patents by PatentIndex Score
24 records- 0195US7652049B2CETP inhibitorsMERCK & CO INC·Filed 2005·Granted Jan 26, 2010·54 cites·54 claims
- 0292US7910592B2CETP inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted Mar 22, 2011·13 cites·15 claims
- 0390US7737295B2CETP inhibitorsMERCK SHARP & DOHME·Filed 2005·Granted Jun 15, 2010·15 cites·16 claims
- 0489US7781426B2CETP inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted Aug 24, 2010·18 cites·12 claims
- 0588US7625937B21H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulatorsMERCK & CO INC·Filed 2007·Granted Dec 1, 2009·11 cites·21 claims
- 0683US8334290B2CETP inhibitorsALI AMJAD·Filed 2006·Granted Dec 18, 2012·5 cites·12 claims
- 0782US8735435B2CETP inhibitorsALI AMJAD·Filed 2009·Granted May 27, 2014·5 cites·9 claims
- 0880US9221834B2Cyclic amine substituted oxazolidinone CETP inhibitorLU ZHIJIAN·Filed 2011·Granted Dec 29, 2015·3 cites·14 claims
- 0977US9682978B22,6,7 substituted purines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jun 20, 2017·2 cites·10 claims
- 1075US8962611B2Substituted imidazopyridines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Feb 24, 2015·1 cites·20 claims
- 1175US8846657B2Substituted imidazopyridines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Sep 30, 2014·1 cites·30 claims
- 1273US7282591B21h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulatorsMERCK & CO INC·Filed 2003·Granted Oct 16, 2007·5 cites·2 claims
- 1371US9725445B2Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 8, 2017·2 cites·17 claims
- 1471US7411073B2Selective non-steroidal glucocorticoid receptor modulatorsMERCK & CO INC·Filed 2004·Granted Aug 12, 2008·5 cites·11 claims
- 1570US9540377B22,6,7,8 substituted purines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jan 10, 2017·2 cites·15 claims
- 1668US8193365B2CETP inhibitorsALI AMJAD·Filed 2010·Granted Jun 5, 2012·1 cites·12 claims
- 1766US9957264B2Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 1, 2018·1 cites·9 claims
- 1860US2014221383A1Cetp inhibitorsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 1951US2016075724A1CETP InhibitorsMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 2044US9637493B2Substituted pyrrolopyrimidines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted May 2, 2017·0 cites·15 claims
- 2143US10059705B2Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 28, 2018·0 cites·7 claims
- 2243US9957265B2N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 1, 2018·0 cites·11 claims
- 2337US9486448B2Pyrrolidine derived beta 3 adrenergic receptor agonistsBARR KENNETH JAY·Filed 2014·Granted Nov 8, 2016·0 cites·14 claims
- 2433US8604038B2Pyrrolidine derived beta 3 adrenergic receptor agonistsEDMONDSON SCOTT D·Filed 2010·Granted Dec 10, 2013·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →